Ecuphar completed the reverse takeover of Animalcare in July 2017 to form today’s Animalcare Group plc (LON: ANCR). The combined group is a pan-European animal health business with own commercial teams across the Benelux, UK, Germany, Spain, Italy and Portugal. Animalcare develops and markets pharmaceutical products for companion animals, horses and production animals. Animalcare has strong growth ambitions (buy & build) and the potential to become the “Omega Pharma of the veterinary sector.”
Alychlo made its first investment in Ecuphar in 2007 and has supported the company's exponential growth since. Today, Alychlo is one of the reference shareholders of Animalcare Group with a stake of approx 23%.
For more information: www.animalcaregroup.co.uk